氧化用于治疗抑郁症:系统性审查和元分析
Kiranpreet Gill1, Angharad N de Cates1, Chantelle Wiseman1
1Institute for Mental Health, University of Birmingham, Birmingham, UK.
EBioMedicine
|December 1, 2025
概括
氧化 (N2O) 在早期对抑郁症的试验中显示出快速的抗抑郁作用. 需要进一步的研究来确定这些益处是否在最佳剂量和重复使用下持续存在.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抑郁症是全球主要的健康问题,需要新的治疗目标.
- 作为NMDA受体对手的氧化 (N2O) 正在研究其快速抗抑郁作用.
- 这项研究综合了目前关于N2O在治疗抑郁症中有效性和安全性的数据.
研究的目的:
- 系统地审查和综合有关氧化 (N2O) 治疗抑郁症的疗效和安全性的数据.
- 评估N2O作为快速起作用的抗抑郁药干预的潜力.
主要方法:
- 按照PRISMA指导方针对临床试验,探索性研究和协议论文进行系统审查.
- 对主要结果的聚合数据的元分析:抑郁症症状变化和不良事件.
- 已完成和正在进行的研究的试验特征的证据映射.
主要成果:
- 有247名参与者的7项试验评估了N2O对抑郁症 (MDD,TRD,双极性抑郁症) 的治疗.
- 单次50%的N2O吸入疗程在2小时和24小时显著降低了抑郁症状,但在1周内没有.
- 副作用是轻微的和短暂的;25%的N2O更好地耐受. 大多数试验都处于早期阶段,专注于短期结果.
结论:
- 在初步研究中,N2O显示出快速和可重现的抗抑郁作用.
- 持续的疗效取决于最佳的剂量和延长/重复的使用.
- 未来的研究需要改进试验设计,标准化结果和多样化的群体,以充分评估N2O的潜力.
更多相关视频
10:54Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
243
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
497
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
774
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
774
Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Depression: Overview
750
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
750
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
Electroconvulsive Therapy
808
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
808
Depressive Disorders: MDD and Dysthymia
581
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
581
